Multicenter, randomized, double-blind, phase 2 study to assess the efficacy and safety of OATD-01, an oral inhibitor of chitinase-1 for the treatment of active pulmonary sarcoidosis.
EUROPEAN RESPIRATORY JOURNAL（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要